top of page

Insights
Topic 1: Translational Medicine
Moderators
DENG Shaoping, President, Sichuan Academy of Medical Science & Sichuan Provincial People’s Hospital
SHI Yuankai, Vice President, Chinese Academy of Medical Science Cancer Hospital, National Lab for Cancer Clinical Trials

ZHANG Xiangcheng
Industry Fellow, Royal Society, United Kingdom
Topic: Innovation in Science and Collaboration: the Past, Present, and Future

YANG Zhenglin
Vice President, Sichuan Academy of Medical Science & Sichuan Provincial People’s Hospital
Topic: Research and Application of Age-related Macular Degeneration in China

YANG Shengyong
Professor, Sichuan University
Topic: Artificial Intelligence and Innovative Medicine Development

Lilach O. Lerman
Professor of Medicine and Physiology in the Mayo Medical School; Director of the Renovascular Research Laboratory, and Head of the Nephrology Research Unit at the Division of Nephrology & Hypertension at Mayo Clinic
Topic: The Obesity Epidemic: Weight and Beyond
Topic 2: Precision Medicine
Moderators
RAO Keqin, Vice President and Chairman, Chinese Medical Association; President, Chinese Health Economics Association
WU Qi, Human Resources and Social Security Department of Sichuan

WEI Yuquan
Director of State Key Laboratory of Biotherapy and Cancer
Center, West China Hospital, Sichuan University; Academician, Chinese Academy of Sciences
Topic: Tumor Micro-environment and Development of Biology Medicine

XU Mei
President, International Richland Hospital, Kunming, Yunnan
Topic: Searching for Cause for Diseases

SHI Yuankai
Vice President, Chinese Academy of Medical Science Cancer Hospital, National Lab for Cancer Clinical Trials
Topic: Current Status and Prospects of Clinical Research on New Cancer Drugs in China

James Meng
President, Mevion Medical Systems, Boston, U.S.
Topic: Precision Cancer Treatment with Miniaturized Proton

Anita Katharina Wagner
Clinical Pharmacist, Pharmacoepidemiologist, and
Health Policy Researcher, Department of Population Medicine of Harvard Medical School & Harvard Pilgrim Health Care Institute
Topic: New Cancer Therapeutics in Health Systems – Opportunities and Challenges
Panel Discussion
Moderator:
MA Jing, Director, China Center, Department of Population Medicine, Harvard Medical School & Harvard Pilgrim Health Care InstituteHE Xin, Managing Partner, Hyfinity Investments

Above Speakers
SHI Anli, President, Cancer Rehabilitation Society of China Anti-Cancer Association
bottom of page